Literature DB >> 16793269

A systematic review of diagnostic studies in myasthenia gravis.

Michael Benatar1.   

Abstract

We performed a systematic review to identify studies that reported the accuracy of tests for the diagnosis of myasthenia gravis. We identified 20 studies of reasonable, although variable, methodological quality upon which to base estimates of the accuracy of the ice test, rest test, Tensilon test, acetylcholine receptor antibodies, repetitive nerve stimulation and single fiber electromyography for the diagnosis of myasthenia gravis. After examining inter-study heterogeneity for each diagnostic modality, we calculated pooled estimates of sensitivity and specificity as well as positive and negative likelihood ratios. Results are reported separately for ocular and generalized myasthenia. Studies that have examined the performance of anti-acetylcholine receptor antibody testing and single fiber electromyography were generally of better quality than those that examined other diagnostic modalities. We suggest that caution should be exercised in the interpretation of the diagnostic performance of these tests given the methodological limitations of the studies upon which test performance is based.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16793269     DOI: 10.1016/j.nmd.2006.05.006

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  41 in total

1.  Techniques and applications of EMG: measuring motor units from structure to function.

Authors:  Rachel C Thornton; Andrew W Michell
Journal:  J Neurol       Date:  2012-01-25       Impact factor: 4.849

Review 2.  Diagnosis and management of autoimmune myasthenia gravis.

Authors:  Corrado Angelini
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

3.  In response to "current approach to seronegative myasthenia" by Z. Argov.

Authors:  Michal Haran
Journal:  J Neurol       Date:  2010-11-18       Impact factor: 4.849

4.  Myasthenia gravis.

Authors:  Pierre R Bourque; Ari Breiner
Journal:  CMAJ       Date:  2018-09-24       Impact factor: 8.262

5.  Treatment of ocular myasthenia gravis.

Authors:  Scott R Haines; Matthew J Thurtell
Journal:  Curr Treat Options Neurol       Date:  2012-02       Impact factor: 3.598

Review 6.  Efficacy and safety of tacrolimus for myasthenia gravis: a systematic review and meta-analysis.

Authors:  Liang Wang; Suxian Zhang; Jianying Xi; Wenhui Li; Lei Zhou; Jun Lu; Jiahong Lu; Tiansong Zhang; Chongbo Zhao
Journal:  J Neurol       Date:  2017-09-18       Impact factor: 4.849

7.  Both binding and blocking antibodies correlate with disease severity in myasthenia gravis.

Authors:  Sa-Yoon Kang; Jung-Hwan Oh; Sook Keun Song; Jung Seok Lee; Jay Chol Choi; Ji-Hoon Kang
Journal:  Neurol Sci       Date:  2015-05-12       Impact factor: 3.307

8.  Sensitivity and specificity of single-fibre EMG in the diagnosis of ocular myasthenia varies accordingly to clinical presentation.

Authors:  Maria Pia Giannoccaro; Vitantonio Di Stasi; Corrado Zanesini; Vincenzo Donadio; Patrizia Avoni; Rocco Liguori
Journal:  J Neurol       Date:  2019-11-16       Impact factor: 4.849

9.  Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.

Authors:  Crandall E Peeler; Lindsey B De Lott; Lina Nagia; Joao Lemos; Eric R Eggenberger; Wayne T Cornblath
Journal:  JAMA Neurol       Date:  2015-10       Impact factor: 18.302

Review 10.  Treatment of Myasthenia Gravis in the Aged.

Authors:  Nuha M Alkhawajah; Joel Oger
Journal:  Drugs Aging       Date:  2015-09       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.